NCT02624102View on ClinicalTrials.gov

Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2019

Conditions
Major Depressive Disorder
Interventions
BEHAVIORAL

Trial based cognitive therapy

Patients with MDD, in use of antidepressants plus Trial Based Cognitive Therapy

BEHAVIORAL

Behavioral Activation

Patients with MDD, in use of antidepressants plus Behavioral Activation

DRUG

Antidepressants

Patients with MDD, in use of antidepressants (fluoxetine, citalopram, escitalopram, bupropion, etc.) without psychotherapy.

Trial Locations (1)

41815340

Curt Hemanny, Salvador

All Listed Sponsors
collaborator

Federal University of Bahia

OTHER

lead

Hemanny, Curt, M.D.

INDIV

NCT02624102 - Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression | Biotech Hunter | Biotech Hunter